ArticleThe Journal of pharmacology and experimental therapeutics2015

Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.

Hilary Nicholson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.